| Schedule of Income before Income Taxes and Equity Income |
| | | | | | | | | | | | | | | | | | | Years Ended December 31, | | 2020 | | 2019 | | 2018 | | U.S. income | $ | 6,881 | | | $ | 3,826 | | | $ | 4,433 | | | Non-U.S. income | 540 | | | 2,342 | | | 1,953 | | | Income before income taxes and equity income | $ | 7,421 | | | $ | 6,168 | | | $ | 6,386 | |
|
| Schedule of Effective Income Tax Rate Reconciliation |
| | | | | | | | | | | | | | | | | | | Years Ended December 31, | | 2020 | | 2019 | | 2018 | | Income tax expense at U.S. federal statutory income tax rate | $ | 1,558 | | | $ | 1,295 | | | $ | 1,341 | | | State and local tax expense | 219 | | | 117 | | | 282 | | | Non-U.S. income taxed at other than the U.S. federal statutory tax rate | (1) | | | 166 | | | 90 | | | U.S. tax impact on Non-U.S. income and activities | (160) | | | (197) | | | (822) | | | Change in valuation allowances | 370 | | | (233) | | | 1,695 | | | Change in tax laws | — | | | (122) | | | (134) | | | General business credits and manufacturing incentives | (366) | | | (420) | | | (695) | | | Capital loss expiration | — | | | — | | | 107 | | | Settlements of prior year tax matters | (18) | | | — | | | (188) | | | Realization of basis differences in affiliates | (12) | | | — | | | (59) | | | German statutory approval of net operating losses | — | | | — | | | (990) | | | Foreign currency remeasurement | (7) | | | 74 | | | 19 | | | Other adjustments | 191 | | | 89 | | | (172) | | | Total income tax expense | $ | 1,774 | | | $ | 769 | | | $ | 474 | |
|
| Schedule of Deferred Tax Assets and Liabilities |
The following table summarizes the components of temporary differences and carryforwards that give rise to deferred tax assets and liabilities: | | | | | | | | | | | | | December 31, 2020 | | December 31, 2019 | | Deferred tax assets | | | | | Postretirement benefits other than pensions | $ | 1,742 | | | $ | 1,695 | | | Pension and other employee benefit plans | 2,999 | | | 2,968 | | | Warranties, dealer and customer allowances, claims and discounts | 5,538 | | | 6,299 | | | | | | | U.S. capitalized research expenditures | 6,763 | | | 6,035 | | | U.S. operating loss and tax credit carryforwards(a) | 7,254 | | | 8,686 | | | Non-U.S. operating loss and tax credit carryforwards(b) | 7,216 | | | 6,731 | | | Miscellaneous | 3,479 | | | 1,965 | | | Total deferred tax assets before valuation allowances | 34,991 | | | 34,379 | | | Less: valuation allowances | (9,095) | | | (8,135) | | | Total deferred tax assets | 25,896 | | | 26,244 | | | Deferred tax liabilities | | | | | Property, plant and equipment | 1,670 | | | 1,565 | | | Intangible assets | 744 | | | 763 | | | Total deferred tax liabilities | 2,414 | | | 2,328 | | | Net deferred tax assets | $ | 23,482 | | | $ | 23,916 | |
_________ (a) At December 31, 2020, U.S. operating loss and tax credit carryforwards of $7.1 billion expire by 2040 if not utilized and the remaining balance of $137 million may be carried forward indefinitely. (b) At December 31, 2020, Non-U.S. operating loss and tax credit carryforwards of $1.3 billion expire by 2040 if not utilized and the remaining balance of $5.9 billion may be carried forward indefinitely.
|
| Schedule of Unrecognized Tax Benefits Roll Forward |
The following table summarizes activity of the total amounts of unrecognized tax benefits: | | | | | | | | | | | | | | | | | | | Years Ended December 31, | | 2020 | | 2019 | | 2018 | | Balance at beginning of period | $ | 775 | | | $ | 1,341 | | | $ | 1,557 | | | Additions to current year tax positions | 435 | | | 18 | | | 292 | | | Additions to prior years' tax positions | 26 | | | 13 | | | 264 | | | Reductions to prior years' tax positions | (132) | | | (501) | | | (244) | | | Reductions in tax positions due to lapse of statutory limitations | (3) | | | (8) | | | (38) | | | Settlements | (10) | | | (93) | | | (450) | | | Other | (5) | | | 5 | | | (40) | | | Balance at end of period | $ | 1,086 | | | $ | 775 | | | $ | 1,341 | |
|